| Literature DB >> 35763485 |
Amrita N Singh1, Victoria Sanchez1, Erin S Kenzie1, Eliana Sullivan1, James L McCormack1, Jean Hiebert Larson1, Alissa Robbins2, Tiffany Weekley1, Brigit A Hatch1,3, Caitlin Dickinson1, Nancy C Elder1,3, John P Muench1,3, Melinda M Davis1,3,4.
Abstract
BACKGROUND: Unhealthy alcohol use (UAU) is a leading cause of morbidity and mortality in the United States, contributing to 95,000 deaths annually. When offered in primary care, screening, brief intervention, referral to treatment (SBIRT), and medication-assisted treatment for alcohol use disorder (MAUD) can effectively address UAU. However, these interventions are not yet routine in primary care clinics. Therefore, our study evaluates tailored implementation support to increase SBIRT and MAUD in primary care.Entities:
Mesh:
Year: 2022 PMID: 35763485 PMCID: PMC9239445 DOI: 10.1371/journal.pone.0269635
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Specific aims, research questions, hypotheses, and data sources (N ~ 150 unless specified).
| Study Aim | Research Question(s) or Hypothesis | Data Source(s) |
|---|---|---|
| 1. Engage, recruit, and conduct needs assessments with 150 primary care clinics and their CCOs within the state of Oregon | • Interviews with CCO leaders (N = 15) | |
| 2. Implement and evaluate the impact of foundational and supplemental implementation support on SBIRT, MAUD, and QI capacity in participating primary care clinics. | • Supplemental implementation support plans | |
| 3. Describe how practice facilitators tailor implementation support based on context, intervention characteristics, and personal expertise using mixed-methods and systems science. | • Baseline assessment | |
CCOs = Coordinated Care Organizations; SBIRT = Screening, brief intervention, and referral to treatment; OHA = Oregon Health Authority; MAUD = Medication-assisted treatment for alcohol use disorder; ORPRN = Oregon Rural Practice-based Research Network; HIT = Health information technology; QI = Quality improvement
Fig 1Hybrid framework combining the Integrated Promoting Action on Research Implementation in Health Services (i-PARIHS) and the Dynamic Sustainability Framework (DSF).
Successful implementation and capacity development are a function of facilitation interacting with the intervention, recipients, practice setting, and the ecological system over time (represented by T0, T1,…,Tn), each of which has constituent components that may vary. HIT = Health information technology; org = Organization; QI = Quality improvement.
Evidence-based interventions recommended for addressing unhealthy alcohol use in primary care.
| Topic | Identified In | Key Finding |
|---|---|---|
| Screening | USPSTF | “The USPSTF recommends screening for unhealthy alcohol use in primary care settings in adults 18 years or older, including pregnant women…” Furthermore, “1-item to 3-item screening instruments have the best accuracy for assessing unhealthy alcohol use in adults 18 years or older.” These include the |
| Brief Intervention | Cochrane Collaboration | Brief intervention (BI) for alcohol misuse consistently produced reductions in alcohol consumption. At follow-up one year later, people who had received BIs drank 6–25g less alcohol per week. BIs include feedback on alcohol use and harms, identification of high-risk situations for drinking and coping strategies, increased motivation and the development of a personal plan to reduce drinking. BIs involve one to four sessions and take place within the timeframe of a standard office visit. Longer counselling showed little additional benefit [ |
| USPSTF | The USPSTF recommends… “providing persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce unhealthy alcohol use.” There are no specific intervention characteristics or components that are clearly associated with improved outcomes [ | |
| Medications for Alcohol Use Disorder | Cochrane Collaboration | The opioid antagonist naltrexone supports cutting down on drinking through reducing alcohol “liking” and “craving”. It reduces risk of returning to heavy drinking (5/4 standard drinks daily) to 83% of placebo, and decreases drinking days by around 4%. NNT = 9 for not returning to heavy drinking [ |
| Compared to placebo, Acamprosate and psychosocial treatment significantly reduce the risk of any drinking (NNT = 9) as well as increasing the cumulative duration of abstinence. Side effects did not cause subjects to stop treatment any more than placebo [ |
USPSTF = United States Preventive Services Task Force; NNT = Number needed to treat
Implementation support strategies.
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
| ||
| Foundational Support | ||||||
| Baseline Assessment | Assessment of capacity, interest, and needs | Practice facilitators | Evaluate context, HIT capacity, and inform supplemental support | QI leads and care team | At baseline (recruitment) | One time: four to six hours |
| Implementation Toolkit | Implementation guide for SBIRT | SBIRT Oregon website | Provide asynchronous access to toolkit, resources, and training materials | Primary: QI leads | Ongoing | Number of visits and reported utilization |
| e-Screening SBIRT tool | Evidence-based tool for screening | Care team members | Provide a clinical decision support screener | Care team members | Ongoing | Number of documented screens |
| Exit Assessment | Assessment of capacity and impact | Practice facilitators | Evaluate context and produce data reports | QI leads and care team | After intervention | One time: three to five hours |
| Supplemental Support | ||||||
| Practice facilitation | Process of interactive problem solving and support | Practice facilitators | Engage leadership; assess workflows; assist with changes; monitor and encourage progress | QI leads | Six months: two hours of (in person and/or virtual) practice facilitation per month | Visit length and intensity are tailored: up to 10 hours direct practice facilitator support |
| HIT support | HIT experts help with data extraction, entry, and review | HIT experts and practice facilitators | Design reports; help practice facilitators teach clinics to run reports and document data | QI leads and/or clinic QI teams; practice facilitators | At start of study, ongoing if needed | Up to five hours |
| Audit and Feedback | Performance data provided for QI | Practice facilitators or QI leads | Audit process measures regarding patient service engagement | QI leads and care team members | Monthly, when possible | Not applicable |
| Peer-to-Peer Learning via Webinars | Education regarding SBIRT elements | Co-investigators | Provide virtual training regarding patient-centered outcomes research evidence and workflows | QI leads and care team members | Live webinars during year one; recordings thereafter | Up to three hours of webinars |
| Peer-to-Peer Learning via Oregon ECHO® Network | Education and reflection regarding MAUD | Co-investigators | Provide telemedicine training for MAUD. | Primary care clinicians | Six sessions over 5 months during year two | Up to six, 90-minute sessions |
| Expert Consultation | Experts in SBIRT, MAUD changes | Co-investigators | Discuss patient-centered outcomes research evidence; review SBIRT metric and workflows | QI leads and/or care team members | As needed to support facilitators | Up to two hours direct practice support |
HIT = Health information technology; QI = Quality improvement; SBIRT = Screening, brief intervention, and referral to treatment; EHR = Electronic health record; MAUD = Medication-assisted treatment for alcohol use disorder; ECHO® = Extension for Community Healthcare Outcomes
Planned data sources, collection strategies, and frequency.
|
|
|
|
|
|---|---|---|---|
| CCO key informant interviews | To understand how CCOs work with clinics to improve SBIRT and MAUD workflows and documentation, inform baseline understanding or regional context, and to support clinic recruitment. | Interviews with CCO leaders | Within first 12 months of project funding |
| Clinic contact logs | To monitor clinic engagement, implementation support, changes in context or recipients, adaptations to the intervention, and changes to care delivery. | Practice facilitators complete in REDCap | Following all clinic interactions |
| Clinic intake Form—Includes SBIRT and MAUD checklist | To describe practice size, staffing, patient population, telehealth utilization, EHR system at time of enrollment. | Survey (online or paper) | Baseline and exit assessment |
| Needs assessment | To understand clinic interest in and experience with SBIRT, MAUD, and QI, and to inform tailored implementation support. | Pre-intervention meeting with clinics | Baseline assessment |
| Workflow observation | To understand how clinics deliver SBIRT and MAUD at baseline; to identify promising leverage points. | Observation by practice facilitator | Baseline assessment |
| HIT capacity assessment | To determine clinic capacity to report SBIRT and MAUD measures; to inform tailored implementation support. | Clinic completes via survey and conversation with practice facilitator | Baseline assessment |
| Supplemental implementation support plan | To lay out anticipated implementation support plan for each clinic. | Developed by practice facilitator | Within four weeks of clinic baseline assessment |
| Practice facilitator key informant interviews | To explore how individual facilitators tailor implementation support and the development of personal expertise. | Interviews with practice facilitators | Every six months |
| Periodic group reflections with practice facilitators | To explore how facilitators tailor implementation support, identify patterns in implementation across clinics, and track adaptations. | Facilitated debriefs with practice facilitators | Monthly |
| SBIRT and MAUD performance data collection | To identify the proportion of eligible patients receiving SBIRT and MAUD (outcome dependent variable) and ability to report the Oregon CCO metric to their regional Medicaid organization. | EHR or manual tracking | Baseline and exit assessment |
| Clinic key informant interviews | To understand how clinics experience implementation support and practice facilitator development over time; to understand tailoring of implementation support and facilitator skill development. | Interviews with clinic primary point of contact | Exit assessment |
a Baseline assessment activities occur within the first three months of project initiation
b Exit assessment activities occur within the last three months of project support (months 13–15)
CCOs = Coordinated Care Organizations; SBIRT = Screening, brief intervention, and referral to treatment; MAUD = Medication-assisted treatment for alcohol use disorder; HIT = Health information technology; REDCap: Research Electronic Data Capture; EHR = Electronic health record